Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04865887
Title Pembrolizumab and Lenvatinib in Advanced Cervical Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Georgetown University

cervical cancer


Lenvatinib + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.